Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 25, 2021
Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade
Xiaowei Liu, Yanlin Feng, Jie Xu, et al.
Cancer Cell
|
January 21, 2015
Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addiction
Gatien Moriceau, Willy Hugo, Aayoung Hong, et al.
Cancer Discovery
|
November 23, 2013
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy
Hubing Shi, Willy Hugo, Xiangju Kong, et al.
Nature Medicine
|
July 24, 2012
MDM4 is a key therapeutic target in cutaneous melanoma
Agnieszka Gembarska, Flavie Luciani, Clare Fedele, et al.
Nature
|
November 25, 2011
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I Poulikakos, Yogindra Persaud, Manickam Janakiraman, et al.
Cell Metabolism
|
November 22, 2024
Dual impacts of serine/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation
Huan Tong, Zedong Jiang, Linlin Song, et al.
Cancer Cell
|
September 13, 2022
Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer
Manli Wang, Xuelan Chen, Ping Tan, et al.
Innovation (Cambridge (Mass.))
|
November 12, 2024
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
Wenxian Wang, Bin Lian, Chunwei Xu, et al.
Imeta
|
January 1, 2025
<i>iMeta</i> Conference 2024: Building an innovative scientific research ecosystem for microbiome and One Health
Yao Wang, Huiyu Hou, Hao Luo, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 25, 2021
Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade
Xiaowei Liu, Yanlin Feng, Jie Xu, et al.
Cancer Cell
|
January 21, 2015
Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addiction
Gatien Moriceau, Willy Hugo, Aayoung Hong, et al.
Cancer Discovery
|
November 23, 2013
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy
Hubing Shi, Willy Hugo, Xiangju Kong, et al.
Nature Medicine
|
July 24, 2012
MDM4 is a key therapeutic target in cutaneous melanoma
Agnieszka Gembarska, Flavie Luciani, Clare Fedele, et al.
Nature
|
November 25, 2011
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I Poulikakos, Yogindra Persaud, Manickam Janakiraman, et al.
Cell Metabolism
|
November 22, 2024
Dual impacts of serine/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation
Huan Tong, Zedong Jiang, Linlin Song, et al.
Cancer Cell
|
September 13, 2022
Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer
Manli Wang, Xuelan Chen, Ping Tan, et al.
Innovation (Cambridge (Mass.))
|
November 12, 2024
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
Wenxian Wang, Bin Lian, Chunwei Xu, et al.
Imeta
|
January 1, 2025
<i>iMeta</i> Conference 2024: Building an innovative scientific research ecosystem for microbiome and One Health
Yao Wang, Huiyu Hou, Hao Luo, et al.
Page
of 9